Overactive bladder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Having nocturnal urination one or more times. -Having diagnosed with overactive bladder. -Not taking anticholinergic drugs prescribed by a doctor for two weeks before trial registration. -Being able to visit our hospital during study periods. -Having agreement with their participation in writing.
Exclusion criteria
Exclusion criteria: -Having residual urine of more than 100ml. -Having diagnosed with prostatic hyperplasia. -Having the underlying disease such as bladder cancer, urinary calculi, inflammatory lower urinary tract. -Having dementia suspects. -Being considered in appropriate by a clinician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary frequency per day before, during and after the intervention period. The urinary frequency is calculated from time of urination recorded in urinary diary. | — |
Secondary
| Measure | Time frame |
|---|---|
| We assess the following outcomes during each period; before, during and after the intervention. -Subjective symptoms of overactive bladder. (with Overactive Bladder Symptoms Score: OABSS) -The influence of overactive bladder symptoms on daily life. (with King's Health Questionnaire: KHQ) -The influence on sleep quality. -Costs associated with care for frequent urination. -Impression of the self-administered intervention (record during intervention periods only). -volume of fluid intake (recorded on urinary diary) | — |
Countries
Japan
Contacts
Tokyo Metropolitan Institute of Gerontology Autonomic Neuroscience